Literature DB >> 7251686

Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol.

T Ishii, I Hishinuma, S Bannai, Y Sugita.   

Abstract

Mouse lymphoma L1210 cells require some thiol compounds (such as 2-mercaptoethanol) or feeder layer cells for their growth in normal culture media in vitro. We found that feeder layer cells (human diploid fibroblast IMR-90) constantly produce thiol compounds; cysteine was the major thiol compound accumulating in the culture medium. In the culture medium of L1210 cells, added cysteine was rapidly oxidized and was toxic to the cells at high concentrations. However, cysteine promoted growth of L1210 cells when it was added repeatedly to the medium at low concentrations. These results show that the major role of feeder layer cells is to provide cysteine continuously. The glutathione content of L1210 cells depended largely on the cysteine concentration in the medium. In normal culture media containing cystine but not cysteine, the cellular glutathione content decreased notably within a few hours. Cysteine had to be supplied repeatedly to keep the content high. Cystine promoted the cellular glutathione content at unphysiologically high concentrations. These results were attributable to the extremely low uptake rate of cystine by the cells as compared with that of cysteine. In the presence of 2-mercaptoethanol, the uptake of radioactive cystine by the cells was increased and a high cellular glutathione level was maintained. A thiol-independent variant of L1210 took up cystine far more rapidly than L1210. From these results we concluded that the deficiency of the cystine uptake limits the growth of L1210 cells in normal culture media.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251686     DOI: 10.1002/jcp.1041070215

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  23 in total

Review 1.  Antigen-presenting cells control T cell proliferation by regulating amino acid availability.

Authors:  Aimee L Edinger; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

Review 2.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

3.  Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells.

Authors:  Zhonghua Yan; Sanjay K Garg; Ruma Banerjee
Journal:  J Biol Chem       Date:  2010-10-30       Impact factor: 5.157

4.  Clonal growth of bladder cancer cells in a double layer soft agar assay: needles addition of multiple culture supplements.

Authors:  K Lee; P Smith; G H Weiss; A T Cockett
Journal:  Urol Res       Date:  1990

Review 5.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

Review 6.  Role of membrane transport in metabolism and function of glutathione in mammals.

Authors:  S Bannai; N Tateishi
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

7.  Mouse lymphoma L1210 cells acquire a new cystine transport activity upon adaptation in vitro.

Authors:  I Hishinuma; T Ishii; H Watanabe; S Bannai
Journal:  In Vitro Cell Dev Biol       Date:  1986-03

8.  The use of murine feeder cells in the cultivation of Plasmodium falciparum asexual blood stages.

Authors:  K R Trenholme; R S Phillips
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

9.  Mercaptoethanol protects glutathione depleted cells.

Authors:  P C Chen; E Gaetjens; J D Broome
Journal:  Agents Actions       Date:  1987-10

10.  Overcoming Therapeutic Challenges for Pancreatic Ductal Adenocarcinoma with xCT Inhibitors.

Authors:  Milica Vucetic; Boutaina Daher; Shamir Cassim; Scott Parks; Jacques Pouyssegur
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.